Saudi Arabia Pharmacy Retail Market to Reach USD 12.67 Billion by 2030

The Saudi Arabia pharmacy retail market is experiencing a significant growth trajectory, driven by increasing demand for healthcare services, particularly due to the country's growing and aging population. Chronic diseases such as diabetes, cardiovascular conditions, and respiratory illnesses are becoming more prevalent, leading to a higher demand for pharmaceutical products. The government's Vision 2030 initiative aims to improve the overall healthcare infrastructure, driving growth in the retail pharmacy sector. The rise in health awareness among consumers, shift towards self-medication, and increasing availability of online pharmacies further contribute to market expansion.

Key Takeaways:

• The Saudi Arabia pharmacy retail market was valued at USD 7.34 Billion in 2024 and is expected to reach USD 12.67 Billion by 2030, rising at a CAGR of 9.53%.
• The increasing demand for healthcare services, particularly due to the country's growing and aging population, is a key driver of market growth.
• Chronic diseases such as diabetes, cardiovascular conditions, and respiratory illnesses are becoming more prevalent, leading to a higher demand for pharmaceutical products.
• Government initiatives like Vision 2030 aim to improve the overall healthcare infrastructure, driving growth in the retail pharmacy sector.
• The rise in health awareness among consumers and a shift towards self-medication also contribute to market expansion.
• The increasing availability of online pharmacies and e-commerce platforms further boosts the retail sector by providing convenient access to medicines and healthcare products.
• As of 2024, diabetes has emerged as a significant public health issue, with an estimated 18.5% of Saudi individuals having the disease.
• The Saudi Arabia pharmacy retail market is expected to be driven by the growth of the e-commerce platform and the rise of online pharmacies.

Statistics:

• The Saudi Arabia pharmacy retail market was valued at USD 7.34 Billion in 2024.
• By 2030, the market is expected to reach USD 12.67 Billion, rising at a CAGR of 9.53%.
• As of 2024, an estimated 18.5% of Saudi individuals have diabetes.
• The country's population is aging, leading to a higher demand for healthcare services and pharmaceutical products.
• The government's Vision 2030 initiative aims to improve the overall healthcare infrastructure, driving growth in the retail pharmacy sector.

Sources:

• "Saudi Arabia Pharmacy Retail Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" (ResearchAndMarkets.com)